Transarterial radioembolization versus tyrosine kinase inhibitor in hepatocellular carcinoma with portal vein thrombosis

BACKGROUND/AIMS: Transarterial radioembolization (TARE) has shown promising results in treating advanced hepatocellular carcinoma (HCC) with portal vein tumor thrombosis (PVTT). However, whether TARE can provide superior or comparable outcomes to tyrosine kinase inhibitor (TKI) in patients with HCC...

Descripción completa

Detalles Bibliográficos
Autores principales: Hur, Moon Haeng, Cho, Yuri, Kim, Do Young, Lee, Jae Seung, Kim, Gyoung Min, Kim, Hyo-Cheol, Sinn, Dong Hyun, Hyun, Dongho, Lee, Han Ah, Seo, Yeon Seok, Lee, In Joon, Park, Joong-Won, Kim, Yoon Jun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Association for the Study of the Liver 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10366806/
https://www.ncbi.nlm.nih.gov/pubmed/37254488
http://dx.doi.org/10.3350/cmh.2023.0076

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10366806/
https://www.ncbi.nlm.nih.gov/pubmed/37254488
http://dx.doi.org/10.3350/cmh.2023.0076

Ejemplares similares